Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10984775 | 1.00 | KMT2A (0.55) | KMT2AL3MBTL1LMNAGFERTEAD4 | |
| SCHEMBL10990207 | 1.00 | KMT2A (0.55) | KMT2AL3MBTL1LMNAGFERTEAD4 | |
| SCHEMBL10993100 | 0.93 | KMT2A (0.60) | KMT2AL3MBTL1LMNAGFERTEAD4 | |
| SCHEMBL47864 | 0.93 | KMT2A (0.60) | KMT2AL3MBTL1LMNAGFERTEAD4 | |
| SCHEMBL47874 | 0.90 | KMT2A (0.57) | KMT2AL3MBTL1LMNAGFERMAPT | |
| SCHEMBL12792078 | 0.87 | KMT2A (0.45) | KMT2AL3MBTL1LMNAGFERTEAD4 | |
| SCHEMBL11947076 | 0.86 | ALDH1A1 (0.63) | KMT2AL3MBTL1LMNAGFERTEAD4 | |
| SCHEMBL10259158 | 0.86 | SMN1; SMN2 (0.62) | KMT2AL3MBTL1LMNAGFERTEAD4 | |
| SCHEMBL16621786 | 0.85 | HTT (0.69) | KMT2AL3MBTL1LMNAGFERMAPT | |
| SCHEMBL20871928 | 0.85 | MAPT (0.49) | KMT2AL3MBTL1LMNAGFERTEAD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4526984-A | Autoxidation of alkyl-substituted aromatic ethers | THE UPJOHN COMPANY (US) | 1985-07-02 | — | — | US | claimed |
| US-11530357-B2 | Liquid crystal alignment agent and liquid crystal panel | SHARP KABUSHIKI KAISHA (JP) | 2022-12-20 | — | — | US | disclosed |
| US-11384169-B2 | Sealant composition, liquid crystal cell, and method of producing liquid crystal cell | SHARP KABUSHIKI KAISHA (JP) | 2022-07-12 | — | — | US | disclosed |
| US-11319514-B2 | Composition for forming a coating film for removing foreign matters | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| US-11201411-B2 | Liquid crystal cell and scanning antenna | SHARP KABUSHIKI KAISHA (JP) | 2021-12-14 | — | — | US | disclosed |
| US-11201403-B2 | Liquid crystal cell and scanning antenna | SHARP KABUSHIKI KAISHA (JP) | 2021-12-14 | — | — | US | disclosed |
| US-11189914-B2 | Liquid crystal cell and scanning antenna | SHARP KABUSHIKI KAISHA (JP) | 2021-11-30 | — | — | US | disclosed |
| US-11078324-B2 | Seal material composition, liquid crystal cell, and scanned antenna | SHARP KABUSHIKI KAISHA (JP) | 2021-08-03 | — | — | US | disclosed |
| US-11079634-B2 | Liquid crystal display device and method for manufacturing same | SHARP KABUSHIKI KAISHA (JP) | 2021-08-03 | — | — | US | disclosed |
| WO-2021131501-A1 | POLYIMIDE RESIN COMPOSITION AND MOLDED BODY | 三菱瓦斯化学株式会社 | 2021-07-01 | — | — | WO | disclosed |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER HEALTHCARE LLC | 2007-10-18 | — | — | US | disclosed |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER HEALTHCARE LLC | 2007-10-18 | — | — | US | disclosed |
| US-20070004228-A1 | Polyamide acid-containing composition for forming antireflective film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20050054882-A1 | Diaryl ether condensation reactions | NSF - DEITR | 2005-03-10 | — | — | US | disclosed |
| US-6762329-B2 | EFFECTS OF ACIDIC ACTIVATORS ON ULLMANN-TYPE COUPLINGS INVOLVING ELECTRON-POOR AND/OR RELATIVELY INSOLUBLE SUBSTRATES. | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2004-07-13 | — | — | US | disclosed |
| US-20030088128-A1 | Diaryl ether condensation reactions | NATIONAL SCIENCE FOUNDATION | 2003-05-08 | — | — | US | disclosed |
| WO-2003007954-A2 | SULFONYL ARYL HYDROXAMATES AND THEIR USE AS MATRIX METALLOPROTEASE INHIBITORS | PHARMACIA CORPORATION (US) | 2003-01-30 | — | — | WO | disclosed |
| US-6395939-B1 | CATALYTIC ETHERIFICATION AND CONDENSATION WITH COPPER CATALYSTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2002-05-28 | — | — | US | disclosed |
| WO-1999018057-A1 | PREPARATION OF DIARYL ETHER BY CONDENSATION REACTIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1999-04-15 | — | — | WO | disclosed |
| US-4526984-A | Autoxidation of alkyl-substituted aromatic ethers | THE UPJOHN COMPANY (US) | 1985-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054882-A1 | Diaryl ether condensation reactions | NSFL1C, DERL1, UBE2M | KMT2A 1576/4885L3MBTL1 3571/4885LMNA 1722/4885 |
| US-20030088128-A1 | Diaryl ether condensation reactions | NSFL1C, DERL1, UBE2M | KMT2A 1576/4885L3MBTL1 3571/4885LMNA 1722/4885 |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BRAF, RAF1, ARAF | KMT2A 1462/4885L3MBTL1 1879/4885LMNA 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.